Enhance your presence at #BIOCEO25 with Company Presentations and showcase your biotech innovations to investors and industry leaders. Don’t miss this opportunity! https://lnkd.in/gYMz2bUD
Biotechnology Innovation Organization
生物技术研究
Washington，DC 94,343 位关注者
BIO, Where breakthroughs begin
关于我们
BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. We also represent state and regional biotech associations, service providers to the industry and academic centers.
- 网站
-
https://www.bio.org
Biotechnology Innovation Organization的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Washington，DC
- 类型
- 非营利机构
- 创立
- 1993
- 领域
- biotech、association、life sciences、biofuels、gmo、cures、energy、agriculture和pharmaceuticals
地点
-
主要
获取路线
1201 New York Ave N.W.
Suite 1300
US，DC，Washington，20005
Biotechnology Innovation Organization员工
动态
-
That’s a wrap on #COP29! We engaged in dynamic discussions with thought leaders from around the world. We shared groundbreaking innovations and strategies that highlight the critical role of biotechnology in fostering a sustainable future. Thank you to Emmanuel Escoto Gonzalez, Kolja Kuse, James Glueck, Eduardo Le?o, Jamaica Gayle, Tamara Muruetagoiena and everyone else who participated and contributed to these meaningful conversations. Let’s continue paving the way for a thriving bioeconomy, prioritizing our planet’s health together.?
-
-
Congratulations to BIO Member BridgeBio on receiving FDA approval for their treatment for transthyretin amyloid cardiomyopathy!
We are excited to announce that the U.S. FDA approved our orally-administered near-complete (≥90%) stabilizer of TTR for the treatment of adult patients with transthyretin cardiac amyloidosis (ATTR-CM).? Next, we're looking to pursue approvals globally in Europe, Japan, and Brazil, and will continue exploring the full potential of this treatment. We are proud of the opportunity to serve patients within this community. Learn more: https://bit.ly/3V5wVp4
-
Earlier this week, BIO’s Clinical Trial Diversity Summit brought together researchers, industry leaders, policymakers, and advocates to address a critical issue in clinical research: improving diversity and inclusion in clinical trials. Read more on Bio.News: https://lnkd.in/eGvuinrY
-
-
Be sure to follow Biotech CEO Sisterhood!
In 2021, Angie You, Julia Owens and Sheila Gujrathi, MD came together with a shared vision: to create a community where women leaders could actively support one another, tackle unique challenges in our field, and help shape the future of science by advancing workplace equality. Today, under 25% of executive roles are held by women — and even fewer women are CEOs. We are the Biotech CEO Sisterhood, and together with our 300+ members, we are here to change the trajectory and narrative for women leaders in our industry. Join us as we work to uplift, inspire, and build a network committed to reshaping biotech. #BiotechCEOSisterhood #WomenInBiotech #Leadership #Innovation #Community #WomenLiftingWomen
-
-
DYK: Every 2.2 minutes someone is diagnosed with lung cancer? During this #LungCancerAwarenessMonth, help us spread awareness and advance research for lung cancer. For more information visit: https://lnkd.in/d_-SWh8G
Anyone with lungs can get lung cancer and early detection leads to better outcomes. Talk to your doctor to discuss your lung cancer risk and if you are eligible for screening. Help raise lung cancer awareness throughout November by visiting lungevity.org/LCAM #AnyoneWithLungs #LCAM #lcsm #lungcancer #lungcancerawareness
-
Biotechnology Innovation Organization转发了
We had an inspiring Friday in the #MassBioHub for our 2024 Patient Advocacy Summit. We were welcomed by Elsa Wilson LaVita, MBA, Director, Patient Advocacy, MorphoSys, followed by opening remarks from MassBio CEO & President Kendalle Burlin O'Connell, Esq. Wendy Poage, Head of Patient Advocacy at Servier Pharmaceuticals shared insights on creating a patient-centric culture. Courtney Dion and Joe Dion of The Dion Foundation sat on a panel with the CEO of Atamyo Therapeutics Stephane Degove, having a moving discussion on what it means to take the step from parent advocates to clinical trial funders. Biotechnology Innovation Organization SVP, External Affairs & Head, Patient Advocacy Center of Excellence Michele Oshman shared personal stories and gave a briefing on what's happening in Washington. Our final panel was "Elevating Black Voices to Achieve Better Health Outcomes" featuring Jessica Russo of the American Cancer Society, Dr. Erica Warner, ScD MPH and cancer survivor Jenina Tyler. Learn more about the initiative here: https://voices.cancer.org View all of the event photos: https://lnkd.in/ef8Ep4Qr Thank you to our sponsors! Sustaining: Massachusetts Life Sciences Center | Thermo Fisher Scientific | Vertex Pharmaceuticals Copper: Novartis | Harvard Pilgrim Health Care | Sanofi | Sumitomo Pharma America, Inc. Supporting: Ultragenyx #MassBioPatientAdvocacySummit | #PatientAdvocacySummit | #PatientDriven
-
-
-
-
-
+4
-
-
Fantastic day at BIO’s Clinical Trial Diversity Summit! Huge thanks to Howard University, our incredible speakers, and everyone who attended for making this event a success!
-
A disconnect between medical expertise & insurance mandates is risking patients' health. Step therapy & prior auth force treatments against doctors' advice—with devastating results. In today's #IAMBIO episode, hear a patient's story, a doctor's challenges, & a biotech leader's fight for better care. ? Listen now: https://lnkd.in/dB4hG3nT
-
-
“Nature is not cruel—just brutally random...The days of a doctor saying ‘there is nothing we can do' is just not acceptable anymore," says BIO's President & CEO John F. Crowley at #MIHealthSummit. Read more about the panel on Bio.News: https://lnkd.in/eDxBinJZ
-